CVR number 32281281
Industry 86.2200 Specialist medical practice activities

PSYKIATRISK LÆGEKLINIK HANS MØRCH JENSEN ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  2.2% 2.3% 2.6% 2.0% 2.0%  
Credit score (0-100)  66 63 61 67 68  
Credit rating  BBB BBB BBB A A  
Credit limit (kDKK)  0.1 0.0 0.0 0.4 0.6  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  602 533 1,007 744 944  
EBITDA  541 472 946 683 881  
EBIT  541 472 946 683 881  
Pre-tax profit (PTP)  708.5 823.5 496.1 1,154.0 1,642.5  
Net earnings  551.7 641.9 384.8 892.2 1,281.4  
Pre-tax profit without non-rec. items  708 824 496 1,154 1,642  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  2,111 2,703 3,037 3,880 5,111  
Interest-bearing liabilities  0.0 0.0 36.6 0.0 0.0  
Balance sheet total (assets)  2,208 2,777 3,168 4,069 5,340  
Net Debt  -2,114 -2,575 -3,007 -3,933 -5,268  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  602 533 1,007 744 944  
Gross profit growth  -0.7% -11.5% 88.9% -26.1% 26.9%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,208 2,777 3,168 4,069 5,340  
Balance sheet change%  26.1% 25.8% 14.1% 28.5% 31.2%  
Added value  540.7 471.6 945.7 682.8 881.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  89.7% 88.5% 93.9% 91.7% 93.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  37.3% 34.2% 37.3% 34.7% 35.6%  
ROI %  39.7% 35.4% 38.4% 36.1% 37.3%  
ROE %  29.7% 26.7% 13.4% 25.8% 28.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  95.6% 97.3% 95.9% 95.3% 95.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -391.0% -545.9% -317.9% -576.0% -597.8%  
Gearing %  0.0% 0.0% 1.2% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 3,345.2% 556.1% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  22.6 37.2 24.2 21.5 23.3  
Current Ratio  22.6 37.2 24.2 21.5 23.3  
Cash and cash equivalent  2,114.0 2,574.7 3,043.3 3,932.7 5,268.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  85.6 261.1 316.6 119.6 174.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 472 946 683 881  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 472 946 683 881  
EBIT / employee  0 472 946 683 881  
Net earnings / employee  0 642 385 892 1,281